The linked FDA records identify Zhengzhou PZ Laser Slim Technology Co., Ltd. as an applicant based in Zhengzhou, Henan, China, with a filing address at 3rd Floor, Bldg. 1, #101 Jinbai Rd., High-Tech Development Zone. Two 510(k) records are linked to the company, both decided Substantially Equivalent (SESE) and both classified under product code GEX, regulation number 878.4810, device class 2, with the advisory committee described as General, Plastic Surgery. The linked collection is a snapshot of the supplied filings as of November 20, 2026 and does not represent total company sales, total portfolio or safety performance. [1][2][6]
The diode laser clearance
K261817 covers the Diode Laser Therapy System under model designations PZ-BDT67-01 and PZ-BDT67-02. The FDA record lists the applicant as Zhengzhou PZ Laser Slim Technology Co., Ltd., contact Xinye Li, with a date received of June 1, 2026 and a decision date of September 17, 2026. The decision code is SESE, the clearance type is Traditional, the third-party flag is N, and the statement or summary field reads Summary. The openFDA device name is Powered Laser Surgical Instrument, and the medical specialty description is General, Plastic Surgery. [1]
The September 17, 2026 letter addressed to the company names the trade device as Diode Laser Therapy System (PZ-BDT67-01, PZ-BDT67-02) and cites regulation number 21 CFR 878.4810, Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology. The same letter references K222064 in connection with EMC, Electrical and Laser Safety and electrical safety testing against IEC standards. The letter does not state clinical outcomes, and none are reported here. [3]
The thulium laser clearance
K261589 covers the 1927nm Thulium Laser System under model designations PZ-DJG85-01 and PZ-DJG85-02. The FDA record lists contact Yueming Li, a date received of May 13, 2026 and a decision date of September 2, 2026, with decision code SESE, Traditional clearance type, third-party flag N and a Summary statement. The device name in the openFDA record is Powered Laser Surgical Instrument, class 2, regulation 878.4810, product code GEX. [2]
The September 2, 2026 letter to Yueming Li, Regulatory Affairs Specialist, names the trade device as 1927nm Thulium Laser System (PZ-DJG85-01, PZ-DJG85-02) and cites 21 CFR 878.4810. The accompanying summary identifies predicate device K252732, a 1927nm Thulium Laser System (PZ-DJG75-01, PZ-DJG75-02) from the same manufacturer, and states that the compared models share intended use, mechanism of action and principle, differing only in pulse width under the dot matrix mode. Non-clinical testing was described as verifying design specifications and substantial equivalence to the predicate. [5]
Applicant identity and registration
The establishment registration and device listing record names ZHENGZHOU PZ LASER SLIM TECHNOLOGY CO., LTD at 3rd Floor, Building 1, No. 101 Jinbai Road, High-tech Development Zone, Zhengzhou City, Henan 450001, CN, with registration number 3013613043. That registration number also appears in the openFDA registration number arrays attached to both 510(k) records. The filing address is a regulatory correspondence address in the FDA records and is not treated here as a verified corporate headquarters. [1][2][6]
The company website at pzlaser.com presents the publisher as Zhengzhou PZ Laser Slim Technology Co, Ltd and describes PZLASER as a medical aesthetic laser manufacturer, listing a featured hair removal laser product and contact details including [email protected] and a telephone number. Those descriptions are the publisher's own and are not corroborated by the FDA filings. No parent company, ownership structure or brand relationship is verified in the public documents. [8]
What the filings establish and what they do not
Both linked records are Traditional 510(k) submissions with SESE decisions and Summary statements, reviewed under the General and Plastic Surgery advisory committee. The supplied collection contains two linked records, both under the 510k pathway, and the sample of two records shows the same two SESE decisions. These counts describe the supplied filings only; they are not a measure of total clearances, commercial activity or device safety. [1][2][9]
A separate FDA letter in the sources addresses K261821, dated August 27, 2026, to the same applicant at the same Jinbai Road address, with regulatory class Class II and product code GEX, dated May 30, 2026 and received June 1, 2026. That submission is not among the two linked portfolio records and is not counted in the collection totals above. No recall records were supplied for this company. [10]


